Media Centre
Full-Year 2018 Results
AstraZeneca has announced its Full-Year 2018 Results on Thursday 14 February 2019.
Go to Full-Year 2018 Results announcementLatest press releases
-
Full-Year 2018 Results
-
US FDA grants Fasenra Orphan Drug Designation for hypereosinophilic syndrome
-
US FDA grants Breakthrough Therapy Designation for potential next-generation RSV medicine MEDI8897
-
EMA grants PRIME eligibility for potential next-generation RSV medicine MEDI8897
-
Forxiga receives positive EU CHMP opinion for the treatment of adults with type-1 diabetes
Medical Releases
These press releases are specifically for health specialist/medical media and are not for consumer press.
Contact us
Gonzalo Viña
Head of Global Media Relations
Rob Skelding
Director Global Media Relations
Matthew Kent
Director Global Media Relations
Christina Malmberg Hägerstrand
Media Relations Director, Sweden and Nordic-Baltic
Jennifer Hursit
Manager Global Media Relations
Lotta Sjösten
Manager Media Relations, Sweden
US Media Team
